Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,427 | 43,194 | 35,904 | 47,167 | 44,747 |
| Marketable Securities | N/A | N/A | 3,502 | N/A | N/A |
| Receivables | 11,779 | 5,418 | 5,796 | 3,510 | 2,066 |
| Inventories | 8,547 | 5,520 | 4,390 | 5,396 | 3,271 |
| Income taxes - deferred | 2,184 | 1,235 | 1,657 | 1,313 | 1,301 |
| TOTAL | $49,830 | $55,831 | $52,443 | $57,606 | $52,410 |
| Non-Current Assets | |||||
| PPE Net | 35,748 | 32,247 | 19,370 | 3,018 | 2,096 |
| Intangibles | 39,935 | 936 | 995 | 0 | 0 |
| Other Non-Current Assets | 3,920 | 6,807 | 6,689 | 7,490 | 8,112 |
| TOTAL | $79,602 | $39,990 | $27,054 | $10,508 | $10,208 |
| Total Assets | $129,431 | $95,821 | $79,497 | $68,114 | $62,618 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,600 | 1,600 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 6,355 | 2,375 | 4,867 | 965 | 1,278 |
| Accrued Expenses | 5,816 | 2,325 | 2,760 | 1,574 | 1,719 |
| TOTAL | $16,522 | $9,033 | $10,637 | $5,461 | $5,827 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,800 | 14,400 | N/A | N/A | N/A |
| Deferred Revenues | 2,752 | 2,732 | 2,807 | 2,905 | 2,830 |
| Other Non-Current Liabilities | 1,775 | 831 | 398 | 65 | 0 |
| TOTAL | $30,766 | $26,031 | $13,898 | $17,164 | $18,900 |
| Total Liabilities | $47,288 | $35,064 | $24,536 | $22,626 | $24,727 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,449 | 11,378 | 11,228 | 10,906 | 10,529 |
| Common Shares | 134 | 114 | 112 | 108 | 105 |
| Retained earnings | 21,470 | 17,782 | 14,153 | 8,118 | 3,513 |
| TOTAL | $82,144 | $60,757 | $54,961 | $45,488 | $37,891 |
| Total Liabilities And Equity | $129,431 | $95,821 | $79,497 | $68,114 | $62,618 |